A CLINICAL STUDY ON THE EFFECT OF SAPTAMRUTA LAUHA IN THE MANAGEMENT OF TIMIRA, WITH SPECIAL REFERENCE TO SIMPLE DEVELOPMENTAL MYOPIA

Dr. Debendra Kumar Sahu*, Dr. Nisha Agrahari

The privilence of Blindness due to Timira (Myopia) is slightly higher in rural as compare to urban area, it constitutes 2% of total population. Considering our effort to ameliorate blindness by 2020 A.D. we should also foucs our attention towards prevention and cure of blindness due to Timira. Total 100 patients of simple developmental myopia were selected and registered according to the plan of study and divided into two groups. 50 patients of trial group Saptamrita loha 500 mg BD was given orally with Grita and Madhu daily, while in placebo group Arraroot powder was given for 3 months. Statistical analysis shows that the trial drug (Saptamrita loha) is significantly effective to reduce the headache, eye strain and visual acuity with p value (<0.001) but clinically we have observed that out of 50 patients, 15 patients has been cured, 09 patients have moderate improvement and mild improvement seen in 15 patients after treatment of 90 days. Where as placebo drug was not able to reduce the sign and symptoms of simple developmental myopia.